Pfizer is doubling down on India as its next growth engine, aiming to bring new medicines to market faster and at more affordable prices. The company sees major opportunity across cancer, obesity and vaccines, backed by plans for local clinical studies to support future launches and tailor outcomes for Indian patients.
A Dutch-flagged cruise ship outbreak has killed three people, and South Africa reported identifying an Andes strain in two evacuated victims. But a widely shared claim tying hantavirus infection to Pfizer’s COVID-19 vaccine is misleading: experts say the referenced document doesn’t confirm hantavirus as a vaccine side effect, and the cases are explained by exposure risks instead.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Pfizer reported higher-than-expected first-quarter sales and profit, boosting investor confidence. The company also pointed to a patent extension for its Vyndamax heart treatment and a favorable European court ruling tied to its COVID-19 vaccine. Together, the wins are expected to help secure stronger growth prospects after 2028.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
